Bridge Biotherapeutics, Inc. (KOSDAQ:288330)

Bridge Biotherapeutics Revenue

Bridge Biotherapeutics had revenue of 9.00M KRW in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to 11.18M, down -88.82% year-over-year. In the year 2024, Bridge Biotherapeutics had annual revenue of 2.18M, down -97.82%.

• Revenue (ttm): 11.18M
• Revenue Growth: -88.82%
• P/S Ratio: 20,894.10
• Revenue / Employee: 319.37K
• Employees: 35
• Market Cap: 233.56B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.18M	-97.82M	-97.82%
Dec 31, 2023	100.00M	-2.92B	-96.69%
Dec 31, 2022	3.02B	1.10B	57.15%
Dec 31, 2021	1.92B	-4.42B	-69.65%
Dec 31, 2020	6.34B	-51.94B	-89.12%